BioAgilytix’s Boston laboratory is located in the heart of the world’s biotech innovation hub and boasts a 20-plus-year track record of delivering premier bioanalytical services along with specialized diagnostic testing.
This facility houses seasoned scientists that collectively have developed, optimized, and validated hundreds of assays for innovative biologic drugs across an array of disease states. We support the full assay lifecycle, from optimization or technology transfer to full validation. This lab can also perform routine sample testing for LDTs or assays developed in-house. We support pharmacetuical and biotechnology innovators of all sizes in their efforts to progress innovative new large molecule drugs to market.
Through BioAgilytix Diagnostics – a division of BioAgilytix and part of our CLIA-certified, CAP-accredited, New York State-licensed Boston laboratory – we offer diagnostic testing services to reference labs for a diverse range of clinical samples, accepted from all 50 states.
We specialize in esoteric testing using FDA-cleared assays and laboratory developed tests (LDTs) for infectious disease testing, diagnostic immunology, vitamin testing, parasite-borne infection testing, and more.
To learn more and explore our full test menu, click here.
At our CLIA-certified, CAP-accredited, and GLP/GCLP-compliant Boston laboratory, we provide premier services for assay development, validation, clinical sample testing, diagnostic testing, kit production, and project management in alignment with a stringent quality system. Our team works across wide range of therapeutic areas and technology platforms to support all aspects of bioanalytical testing for clinical trials. Our test methods include PK/PD analysis, immunogenicity, cell-based assays, biomarker analysis, and more.
Our work supports development programs for all biologics, including gene and cell therapies, antibody-drug conjugates (ADCs), and immuno-oncology solutions. Learn more about our capabilities related to:
Immuno-oncologyImmuno-oncology
Gene TherapyGene Therapy
Diagnostic Testing Services
Through our Boston laboratory we provide premier services to develop, validate, and perform laboratory developed tests (LDTs) and FDA-cleared assays.
Leveraging a wide variety of technology choices, we are able to provide a multifaceted approach to assay development and technology transfer services – helping to ensure your drug candidate reaches its fullest potential through delivery of efficient, high-quality, accurate testing results. Platforms available in our Boston lab include:
qPCR
Roche cobas®
ELISA
Flow Cytometry
Luminex Bio-Plex
MSD-ECL
The Cambridge Biomedical team that has joined BioAgilytix brings with them a 20+ year track record providing customized bioanalytical solutions that deliver reliable, high-quality data. You’ll benefit from the unparalleled scientific knowledge they bring to the bench in support of your innovative drug development programs.
All of our projects are led by directors at a Ph.D. or M.S. level, who possess at least 15 years of industry experience and who will work side-by-side with your team to ensure your milestones and goals are met. Our scientists specialize in novel and esoteric large molecule drug development programs, and our quality assurance team is comprised of seasoned professionals well-versed in the complex regulatory requirements and quality systems that relate to biologics development. In fact, the Boston lab is:
Looking for a lab that commits to the high scientific and quality standards, every time? Our Boston team works tirelessly to deliver the innovative science and committed service you need to advance breakthroughs in patient care — ever mindful of the ultimate beneficiary of our collective efforts.
To learn more about our Boston lab and the premier services we provide, please contact:
BioAgilytix
Boston Location
617.456 .0700
1320 Soldiers Field Road, Boston, MA 02135
Platforms
Services
